Trident Lifeline Limited (BOM:543616)
India · Delayed Price · Currency is INR 249.80
-3.65 (-1.44%)
At close: May 26, 2026
Trident Lifeline Revenue
In the fiscal year ending March 31, 2026, Trident Lifeline had annual revenue of 1.29B INR with 48.36% growth. Trident Lifeline had revenue of 484.11M in the quarter ending March 31, 2026, with 5.14% growth.
Revenue
1.29B
Revenue Growth
+48.36%
P/S Ratio
2.30
Revenue / Employee
17.44M
Employees
74
Market Cap
2.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.29B | 420.57M | 48.36% |
| Mar 31, 2025 | 869.65M | 423.36M | 94.86% |
| Mar 31, 2024 | 446.29M | 129.36M | 40.82% |
| Mar 31, 2023 | 316.92M | 99.24M | 45.59% |
| Mar 31, 2022 | 217.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Albert David | 3.34B |
| Amanta Healthcare | 2.91B |
| Ambalal Sarabhai Enterprises | 2.17B |
| Medico Remedies | 2.12B |
| Sat Kartar Life | 2.01B |
| Everest Organics | 1.89B |
| Medicamen Biotech | 1.72B |
| Gennex Laboratories | 1.52B |